| Quest – Discovery Stage Research Projects | Gladstone Institutes, J. David | Modified RNA-Based Gene Therapy for Cardiac Regeneration Through Cardiomyocyte Proliferation |
$1,565,784 |
| Quest – Discovery Stage Research Projects | Gladstone Institutes, J. David | Direct Cardiac Reprogramming for Regenerative Medicine |
$2,392,157 |
| Quest – Discovery Stage Research Projects | Gladstone Institutes, J. David | Use of Human iPSC-derived Endothelial Cells for Calcific Aortic Valve Disease Therapeutics |
$2,400,048 |
| Conference | Gladstone Institutes, J. David | ISSCR – Roddenberry International Symposium on Cellular reprogramming |
$43,000 |
| Conference | Gladstone Institutes, J. David | Keystone Symposia, “Stem Cells and Reprogramming” |
$50,000 |
| Disease Team Planning | Gladstone Institutes, J. David | Pluripotent Stem Cell–Based Therapy for Heart Disease |
$13,505 |
| Early Translational III | Gladstone Institutes, J. David | Direct Cardiac Reprogramming for Heart Regeneration |
$5,795,871 |
| Basic Biology III | Gladstone Institutes, J. David | Mechanisms of Direct Cardiac Reprogramming |
$1,572,380 |
| Shared Labs | Gladstone Institutes, J. David | The Gladstone CIRM Shared Human Embryonic Stem Cell Core Laboratory |
$842,672 |
| Shared Labs | Gladstone Institutes, J. David | The Gladstone CIRM Shared Human Embryonic Stem Cell Core Laboratory |
$1,698,515 |
| Comprehensive Grant | Gladstone Institutes, J. David | microRNA Regulation of Cardiomyocyte Differentiation from Human Embryonic Stem Cells |
$2,994,719 |
